- Vouliez-vous dire
- vaccines
Résultats de la recherche - 7 results
Barriers to and facilitators of compliance with clinic-based cervical cancer screening: population-based cohort study of women aged 23-60 years.
(i.e., did not attend screening within 1 year of the initial invitation), 51% of whom stated difficulties in taking time off work. 64% of all respondents knew that HPV vaccination was available; only 34% ...
Early effects of human papillomavirus vaccination in Belgium.
Infections Papillomavirus Vaccines Poisson Distribution prevalence regression analysis Retrospective Studies Uterine Cervical Neoplasms Vaginal Smears Young adult Abstract: Human papillomavirus (HPV) ...
Are 20 human papillomavirus types causing cervical cancer?
vaccines, given their rarity in cervical cancers. Health Topics: Cancer Cancer Kanker Service: Centre du cancer Kankercentrum Cancer centre Manuscript versions: DOI: https://doi.org/10.1002/path.4424 ...
HPV DNA, E6/E7 mRNA, and p16INK4a detection in head and neck cancers: a systematic review and meta-analysis
prophylactic vaccines. FUNDING European Commission. Health Topics: Quality of healthcare Qualité des soins de santé Kwaliteit van de gezondheidszorg Cancer Cancer Kanker Service: Centre du cancer Kankercentrum Cancer ...
Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors.
Keywords: clinical efficacy immunogenicity prophylactic HPV vaccines Abstract: This is the protocol for a review and there is no abstract. The objectives are as follows: To evaluate the immunogenicity, ...
Introduction of human papillomavirus (HPV) vaccination in Belgium, 2007-2008.
Adult Belgium Carcinoma, Squamous Cell Child Female Guideline Adherence HEALTH POLICY Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 Humans Insurance, Health, Reimbursement ...
The challenges of organising cervical screening programmes in the 15 old member states of the European Union.
regional programmes commenced in Portugal and Spain. Introduction of new methods of prevention, such as HPV screening and prophylactic HPV vaccination, can reduce the burden further, but this will require ...